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This paper presents the development and validation of a fully automated, high-throughput 14 
multiclass, multiresidue method for quantitative analysis of 77 veterinary drugs in chicken 15 
muscle via direct immersion solid phase microextraction (DI-SPME) and ultra-high pressure 16 
liquid chromatography-electrospray ionization - tandem mass spectrometry (UHPLC-ESI-17 
MS/MS). The selected drugs represent more than 12 different classes of drugs characterized by 18 
varying physical and chemical properties. A Hydrophilic–lipophilic balance 19 
(HLB)/polyacrylonitrile (PAN) extraction phase, preared using HLB particles synthesized in-20 
house, yielded the best extraction/desorption performance among four different SPME extraction 21 
phases evaluated in the current work. The developed SPME method was optimized in terms of 22 
SPME coating and geometry, desorption solvent, extraction and rinsing conditions, and 23 
extraction and desorption times. Multivariate analysis was performed to determine the optimal 24 
desorption solvent for the proposed application. The developed method was validated according 25 
to the Food and Drug Administration (FDA) guidelines, taking into account Canadian maximum 26 
residue limits (MRLs) and US maximum tolerance leves for veterinary drugs in meat. Method 27 
accuracy ranged from 80 to 120% for at least 73 compounds, with relative standard deviation of 28 
1 to 15%. Inter-day precision ranged from 4–15% for 70 compounds. Determination coefficients 29 
values were higher than 0.991 for all compounds under study with no significant lack of fit (p > 30 
0.05) at the 5% level. In terms of limits of quantitation, the method was able to meet both 31 















1. Introduction 33 
As per current agricultural practices, animals raised for food are often housed and transported in 34 
high densities, which makes them more prone to increased levels of stress and disease. Aiming to 35 
minimize livestock losses and increase production, veterinary drugs (VDs) are thus frequently 36 
used to prevent and treat diseases, as well as promote weight gain [1,2]. In this regard, illegal or 37 
improper dosage of VDs as well as failure to comply with stipulated withdrawal dates may lead 38 
to the presence of drug residues in the edible tissue of the treated animal. These residues, even at 39 
low concentrations, may in turn pose a risk to human health [2]. In this respect, one of the main 40 
concerns arising from the overuse of antibiotics in animals is the emergence of resistant bacteria 41 
[3]. 42 
Aiming to protect human health, most governments and ssociated agencies have established 43 
monitoring and regulation laws, standards, and procedures with respect to veterinary drug 44 
residues in the edible tissues of food-producing anim ls [4,5]. To this end, maximum residue 45 
levels (MRLs), defined as the maximum concentration of residue that can safely remain in the 46 
edible tissue of an animal that has been treated with a veterinary drug, are established to set and 47 
enforce these regulatory standards [6]. In Canada, VD residues are regulated by MRLs 48 
established by the Veterinary Drugs Directorate of Health Canada. Likewise, in the USA, 49 
regulatory tolerances of registered veterinary drugs are set by the Food and Drug Administration 50 
(FDA) Center for Veterinary Medicine [7]. In the European Union (EU), the use of veterinary 51 
drugs is also strictly regulated through EU Council Regulation 2377/90/ EC [8]. At the 52 
international level, MRLs are established by Codex Alimentarius, a joint initiative between the 53 















employed in the establishment and monitoring of trading standards so as to ensure the quality of 55 
imported and exported meat [10,11].  56 
Given the growing public interest and concern regarding food safety, and taking into account the 57 
importance of the meat industry to the global economy, the demand for simple, automated high-58 
throughput analytical procedures for monitoring of drug residues in meat is expected to continue 59 
growing. Within this same context, cost-effectiveness plays a large role in analytical method 60 
selection, particularly for laboratories that provide regulatory testing for VD residues. In this 61 
respect, one approach to increase the efficiency and cost-effectiveness of an assay is to increase 62 
the number of analytes that can be determined in a si gle run or method. Consequently, multi-63 
residue, multi-class analytical methods have been gai ing popularity as cost-effective methods 64 
for screening, identification, and quantification of drug residues in food [12]. 65 
Despite the high selectivity and specificity afforded by LC-MS/MS platforms, analysis of VDs at 66 
trace levels in complex matrices, such as animal tissues, still requires extensive sample 67 
preparation procedures aimed at isolating target analytes from complex matrix constituents, and 68 
minimizing interferences and matrix effects [13]. In this respect, multiresidue sample preparation 69 
poses a large challenge to analysts due to two main factors: the large quantity and variety of 70 
analytes under consideration, and the complexity of the matrix under study. A suitable sample 71 
preparation method must enable the detection and quantification of a large quantity of analytes, 72 
encompassing a wide range of physical/chemical properties, while offering sufficient sample 73 
clean-up so as to minimize interferences and matrix effects – a challenging prospect, given that 74 
the studied matrix is characterized by the presence of ndogenous compounds as well as 75 
macromolecules such as proteins and lipids. One of the first and most commonly employed 76 















liquid extraction of analytes from homogenized animal [9]. While this method offers a quick and 78 
simple workflow, it also involves the co-extraction f a high number of endogenous sample 79 
compounds, which may cause matrix effects in LC-MS/ analysis. Other disadvantages 80 
include the possibility of emulsion formation and the use of large volumes of toxic organic 81 
solvents [14]. To minimize interferences and matrix effects, solid phase extraction (SPE) is 82 
commonly used for further sample pre-treatment [15]. Another extraction method that offers 83 
purification of sample interferences in complex matrices is dispersive SPE (dSPE), which is 84 
widely applied in the QuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe) method 85 
[16–18]. However, while SPE and dSPE techniques are wid ly employed for sample preparation, 86 
such approaches do not always effectively eliminate matrix effects, and may sometimes retain 87 
target analytes, thus leading to analyte loss [3,13]. Further, owing to the multiple steps often 88 
involved in such methods, employment of such sample preparation strategy may involve long 89 
analysis times, the introduction of errors, as well as arge costs [19]. 90 
As a well-established and environmentally friendly sample preparation technique, SPME enables 91 
the attainment of clean sample extracts while minimizing matrix interferences from biological 92 
samples [20–22]. Matrix-compatible SPME coatings offer adequate robustness for direct 93 
immersion in complex matrices and balanced extraction coverage of compounds with a wide 94 
range of polarities [23].[24]. [25]. Matrix-compatible coatings, when combined with the open-95 
bed configuration of SPME, facilitate extraction of multiresidue compounds from complex 96 
matrices without being burdened by the clogging issue  typical of conventional SPE packed bed 97 
systems [26]. Boyaci et al. recently developed a fully automated high-throughput thin-film solid 98 
phase microextraction (TF-SPME) method where TF-SPME blades coated with C18 99 















Agency (WADA) from urine [27]. Among the many configurations offered by SPME, SPME 101 
thin-films are consisted of a higher surface area as compared to the conventional SPME fiber 102 
format, and a comparable or lower thickness [28]. Further, as thin-film SPME offers high-103 
throughput compatibility, use of thin-film SPME offers enhanced throughput of the extraction 104 
process due to the simultaneous extraction of 96 individual samples, with minimal use of organic 105 
solvents. Another approach to increase surface area and enhance recovery is the use of round 106 
SPME devices with larger outer diameters [29,30]. The purpose of the presented work entailed 107 
the development of a simple, green, automated, high t roughput sample preparation method for 108 
determination of a wide range of veterinary drugs at regulatory levels in chicken muscle. 109 
Automated sample preparation improves precision and reproducibility due to the elimination of 110 
human error from the procedure. Thus, an automated high throughput DI-SPME LC-MS/MS 111 
method is presented in this paper for analysis of 77 veterinary drug compounds in homogenized 112 
tissue from chicken.  113 
2. Experimental  114 
2.1. Chemicals and Materials 115 
The veterinary drugs under study were selected fromthe list of standards specified in the official 116 
method for screening and confirmation of animal drug esidues developed by the United States 117 
Department of Agriculture (CLG-MRM1.08) [31] and referred to by Schneider et al. [12]. 118 
Depending on availability of standards, we aimed to include as many analytes from the list which 119 
cover a wide range of polarities representing at lest 12 classes. Standards were obtained from 120 
suppliers listed in the Electronic Supplementary Data in Table S-1. The corresponding class of 121 
each target analyte is presented in Table S-2. LC-MS grade acetonitrile (MeCN), methanol 122 















Scientific (Mississauga, ON, Canada). Polyacrylonitrile (PAN), Dimethyl sulfoxide (DMSO), 124 
and N, N-dimethylformamide (DMF), divinylbenzene, N-vinylpyrrolidone, and 2, 2-azobis 125 
(isobutyronitrile) were obtained from Sigma Aldrich (Oakville, ON, Canada). Nunc U96 Deep 126 
Well 2 mL and 1 mL plates made of polypropylene were purchased from VWR International 127 
(Mississauga, ON, Canada). Polypropylene inserts (600 µL) for the 1mL plates were purchased 128 
from Analytical Sales and Services (NJ, USA). For preparation of SPME coatings, C8-129 
benzenesulfonic acid (Mix-mode) was obtained from Supelco (Bellefonte, PA, USA), PS-DVB 130 
was purchased from Chromabond, Germany, and HLB particles were synthesized in-house as per 131 
the protocol discussed in section 2.3. High-tolerance 304 stainless steel rods (1/16” diameter) 132 
were obtained from McMaster-Carr (Aurora, OH, USA) for use as SPME pins.  133 
Stock solutions of veterinary drugs and deuterated internal standard were prepared by weighing 134 
approximately 5 mg of each individual standard, anddissolving individual quantities in 5mL of 135 
either MeCN, MeOH, water, or 10% DMSO in eCN, in accordance with the solubility of each 136 
compound. An internal standard (IS) solution, containing flunixin-d3 at 10 ng mL-1, was 137 
prepared by appropriate dilution of IS stock solutin n MeCN. All target analytes were mixed in 138 
a composite solution and diluted to 100X, where X represents the MRLs listed in Table 1 with 139 
MeCN, with the exception of the β-lactams/cephalosporins composite solution, which was 140 
prepared and diluted in water at a concentration of 200X. All stock and composite solutions were 141 
stored at −30 °C. Spiking solutions and their dilutions were prepared daily for validation 142 
experiments.With the exception of β-lactams/cephalosporins solutions, which were stored in 143 
plastic, all other standard and composite solutions were stored in amber glass vials closed with 144 















The MRL values displayed in Table 1 were based primarily on Canadian MRL values [6] in 146 
poultry, or US tolerance levels [32] in cases where MRL values corresponding to certain analytes 147 
were not available in the Canadian database. In cases where MRL values were unavailable for 148 
poultry in either database, values in other tissues, such as bovine tissue, were selected instead. In 149 
cases where Canadian MRLs were higher than US toleranc  levels, such as that established for 150 
Ketoprofen, the US regulatory value was selected. 151 
Antibiotic free chicken breast, thighs, and liver from five different sources were purchased from 152 
local grocery stores to serve as matrix. Chicken thighs and liver tissue were used only for matrix 153 
effects experiments. Each sample was homogenized separat ly with dry ice, using a Vitamix 154 
blender to obtain a uniform powder. All samples were then combined and ground again with dry 155 
ice to produce a pooled matrix. All homogenized samples were first stored in glass jars covered 156 
by loose lids overnight at −30 °C to allow for sublimation of dry ice to occur, then subsequently 157 
stored at −80 °C until analysis. 158 
2.2. LC-MS/MS method 159 
Experiments were performed with the use of a Thermo Accela 1250 pump with an on-line 160 
vacuum degasser liquid chromatography system coupled to a triple quadrupole mass 161 
spectrometer TSQ Vantage (Thermo Scientific, San Jose, USA). Further instrumental details and 162 
optimized LC and MS/MS parameters are provided in Supplementary data, Tables S-2, S-3, and 163 
S-4. The autosampler, thermostated at 5 ºC, was used for high throughput, 10 µL sample 164 
injections in full loop mode. A Waters (Mississauga, ON, Canada) Acquity UPLC HSS T3 165 
(100×2.1 mm, 1.7µm) analytical column connected to a guard column (HSS T3, 2.1 x 5mm, 166 
1.7µm) was used for separation of the targeted analytes. The column compartment was 167 















clean the injection system (flush and wash volumes w re 1000 µL and 200µL, respectively). The 169 
mobile phases were water (solvent A) and MeCN (Solvent B), each containing 0.1% (v/v) formic 170 
acid. The gradient was run at 3% B for 1 min, ramped linearly to 100% B until 11 min, and then 171 
held at 100% B until 13 min. The column was then returned to 3% B over 2 min, where it was 172 
allowed to re-equilibrate for 3 min. MS data was processed using Xcalibur software v.2.1 173 
(Thermo Fisher Scientific, San Jose, USA). Mobile phases were degassed for 30 min in a VWR 174 
Scientific, Aquasonic model 75HT (West Chester, PA,USA) ultrasonic bath before use. 175 
2.3. Synthesis of Hydrophilic-Lipophilic Balance (HLB) particles 176 
HLB particles were synthesized via precipitation polymerization by modifying the procedure 177 
described elsewhere [33,34], however it was scaled up and toluene was used as a porogen in 178 
order to prepare mesoporous particles. First, 450 mL MeCN and 150 mL toluene were added in a 179 
2L three-necked round bottom flask equipped with a mechanical stirrer and an inlet for nitrogen 180 
gas purging, then purged with nitrogen for 30 min. Following, 42 mL of the monomer/cross 181 
linker (DVB) and 18 mL of the functional monomer (N-VP) were added to the solvent mixture. 182 
AIBN (500mg) was used as an initiator for the polymerization reaction. Particles were rinsed and 183 
dried as per previous methods.  184 
HLB particles were characterized by UltraPlus field mission scanning electron microscopy (FE-185 
SEM, Carl Zeiss, Germany), specific surface area analysis (Autosorb iQ-MP by Quantachrome 186 
(Boyton Beach, Florida)), for determinations of size and shape, and surface area, respectively. 187 
2.4. Automated Concept 96-pin SPME System 188 
The Concept 96 robotic sample preparation station (Professional Analytical System (PAS) 189 















automated, software-operated, off-line bench top robotic station (Figure. 1). The device executes 191 
all steps of the SPME protocol, including preconditioning of the sorbent, SPME extraction, 192 
rinsing, and solvent desorption. In addition, the system also contains an evaporation unit that 193 
allows for optional drying and reconstitution of extracts and/or preconcentration of analytes. The 194 
SPME brush is comprised of 96 SPME pins coated withex raction phase (Figure. 1). The brush 195 
fits standard commercial 96-well-plates, which can be accommodated on the agitators used 196 
during subsequent steps of the method, and is compatible with most autosamplers available for 197 
standard LC systems. 198 
Stainless steel rods for the SPME brush were cut to a length of 50 mm at the University of 199 
Waterloo's Science Technical Services. The SPME coating was comprised of HLB particles 200 
suspended in PAN, and immobilized on the stainless steel rod surfaces of the 96-pin SPME brush 201 
by dip coating, as per the protocol developed by Gomez-Ríos at al [35]. All prepared coatings 202 
had the same length (20mm) and thickness (60µm). 203 
2.5. Automated SPME Procedure for High-Throughput Analysis 204 
Spiked chicken samples were prepared by adding 100 µL of the working solution, containing all 205 
analytes under study at their respective designated concentrations, and 30 µL of the internal 206 
standard working solution to 2.0 g of homogenized chicken tissue. Samples were vortexed 207 
manually for 1 min, then placed on a benchtop agitator for 1h. Samples were then placed in a 4ºC 208 
fridge overnight so as to allow for binding equilibria between matrix and analytes to be 209 
established. Following overnight refrigeration, chicken samples were placed on the benchtop 210 
agitator for 1h prior to extraction so as to allow samples to reach room temperature. 6 mL of 211 















min in order to attain homogeneous consistency, and a viscosity suitable for pipetting of samples 213 
to wells of the 96 well-plates. Next, 1.5 mL of the diluted chicken samples were transferred to 96 214 
well plates. All final diluted spiked samples had an organic solvent content equivalent to less 215 
than 2%.  216 
The Concept 96 system was programmed to consecutively perform the preconditioning of fibers, 217 
SPME extraction, fiber rinsing, and solvent desorpti n. The SPME protocol was executed as 218 
follows: prior to extractions, SPME rods were conditioned for 30 min with 1 mL of 219 
methanol/water (50:50, v/v) in 96-well-plates with agitation (900 rpm). Next, extractions were 220 
performed from 1.5 mL of diluted chicken tissue samples spiked with the target compounds. For 221 
coating and desorption solvent selection, sample matrix was 1 mL of PBS spiked with each 222 
target analyte at 50 ng mL-1. Chicken matrix was used for all subsequent steps of the study. The 223 
final optimized extraction parameters were static extraction for 60 min at 50 ºC. In the fiber 224 
rinsing step, SPME pins were rinsed with 1 mL of water for 10 s with agitation (900 rpm). 225 
Following, desorption of analytes was carried out in 400 µL of desorption solvent (in the final 226 
method) for 20 min with agitation (1200 rpm) in a new 96-well-plate containing desorption 227 
solvent. In order to evaluate carryover for each pair of sorbent and desorption solvents, second 228 
and third sequential desorption steps were carried out under the same conditions. Lastly, the 96-229 
well-plate containing final extracts was covered with the 96-well-plate lid, and placed in the LC-230 
MS/MS autosampler for further analysis. 231 
The final optimized SPME conditions for preconditioning, extraction, rinsing, and desorption 232 
steps are shown in Figure. 1, while protocols for preparation of the used solutions as well as 233 
further details regarding the full analytical procedure can be found in Supplementary data, Figure 234 















2.6. Optimization of the desorption solvent by experimental design 236 
The composition of the desorption solvent was optimized for effectiveness with respect to ratios 237 
of water, methanol, and acetonitrile. Experiments to optimize the desorption solvent were 238 
designed based on a simplex-lattice mixture design (SLMD) introduced by Scheffé [36]. The 239 
design consists of a symmetrical arrangement of points, referred to as {k, m}-lattice, where k is 240 
the number of components, and m is the polynomial model degree. According to Scheffé, in 241 
order to better elucidate the shape of the response surface, the best design option comprises the 242 
use of a design where points are spread evenly over the whole simplex. The uniformly spaced 243 
distribution of points on a simplex is known as a lattice. In addition, the summation of the three 244 
portions (factors) in the SLMD must be equal to one. I  cases where the optimization process 245 
involves multiple responses, it is not feasible to individually optimize each response, as such 246 
would necessitate the use of a large number of samples, equal to the dependent variable under 247 
study [37]. The Derringer & Suich approach presents a  alternative to overcome this drawback, 248 
as it allows for the discovery of the best compromised conditions among all investigated 249 
responses through the desirability function [38,39]. In total, 14 experiments in triplicate were 250 
performed as listed in Supplementary data, Table S-5. Solvent ratios were established through an 251 
SLMD with three components, and the polynomial model gree equal to three. Statistical 252 
evaluation of data from these experiments was performed with the use of Statistica 13.0 software 253 
(TIBCO® Statistica™, CA, USA). 254 
2.7. Validation of the method 255 
The developed method was validated following the guidelines established by the FDA for 256 















of selectivity, linearity, accuracy, intra- and inter-day precision, stability, and limits of 258 
quantification (LOQs). Calibration curves as well as statistical tests were attained with Origin 259 
2018 software (OriginLab Corporation®, MA, USA). 260 
The first step in the validation procedure entailed an evaluation of the selectivity of the method. 261 
Method selectivity was assessed through an analysis of 10 blank chicken tissue samples.  262 
Matrix-matched calibration with internal standard (IS) correction was selected as a calibration 263 
method for the current work. The matrix-matched calibr tion curve was prepared by spiking 264 
analytes in one lot of blank pooled chicken. Flunixin-d3 was added to samples as internal 265 
standard to compensate for sample variations with respect to matrix, variations from pin to pin, 266 
as well as variations in desorption solvent loss due to evaporation during the desorption step. 267 
The linear dynamic range of the LC-MS instrument was determined for each analyte by direct 268 
injection of the neat standards prepared in desorption solution. In order to determine the linearity 269 
of the method, calibration curve solutions were prepa d in a range of 0.1X to 3X in pooled 270 
chicken, and analyzed with the proposed SPME-LC-MS method in triplicate. For determinations 271 
of accuracy and precision, target analytes were spiked at low-, mid- and high concentration 272 
levels (0.3X, 0.9X and 2.5X) in pooled chicken matrix. Internal standard (Flunixin-d3) was 273 
spiked in pooled chicken matrix at 30 ng mL−1. These extractions were performed in six 274 
replicates for intraday precision. Interday precision was evaluated by running three different 275 
experiments over three different days. 276 
The stability of the analytes in the desorption solvent for the duration of the analysis period was 277 
also assessed. Supposing that one run of the experiment utilizes every one of the 96 SPME pin 278 
spaces available in the Concept 96, and taking into acc unt that a total chromatographic time of 279 















complete analysis for each dataset. In addition to the 48 h period, periods of 72 h and one week 281 
were also considered in the stability evaluation. Stability samples were prepared in desorption 282 
solvent, stored at 5ºC, and analyzed after 48 h, 72 h, and 1 week; the attained results were then 283 
compared with those of freshly prepared standards. 284 
3. Results and discussion  285 
3.1. LC-MS method 286 
The method was optimized with respect to run time, retention time stability, chromatographic 287 
separation, carryover, and sensitivity. Chromatographic separation is especially important in the 288 
presence of isobaric compounds such as sulfadoxine and sulfadimethoxine, tetracycline, and 289 
doxycycline [41]. To this end, different chromatographic columns with different chemistry from 290 
various suppliers were tested with respect to their p rformance for the analytes under study. 291 
Based on the results attained in this comparative sudy, a Waters Acquity T3 C18 HSS (100x2.1 292 
mm, 1.7 µm) column was selected for further experimnts, as it provided the best performance 293 
compared to the other evaluated columns in terms of retention of target analytes, as well as peak 294 
shapes and resolution. Quality control (QC) samples were run to verify retention time, 295 
reproducibility, and instrumental performance. QC samples constituted of extracted blank 296 
chicken matrix spiked at 0.5X. The criteria used for verification were: retention time to verify 297 
that all analytes fall in retention time windows, peak shape, as well as peak area of the internal 298 
standard to make sure it does not deviate by more than 20% from the averages obtained during 299 
the initial calibration. 300 















Method optimization was carried out as per the protoc l suggested by Risticevic et al [42]. 302 
Evaluated parameters included coating chemistry, desorption solvent, extraction and desorption 303 
times, agitation rates for extraction and desorption, extraction temperature, and sample and 304 
desorption solvent volumes. The first, and most important step in SPME method development 305 
entails the selection of a suitable coating in terms of extraction efficiency and carryover. Coating 306 
selection is especially important when targeting a large number of analytes with a wide range of 307 
polarities such as the ones targeted in this work, which present log P values ranging from -1.50 308 
to 8.67. For this purpose, different polymer chemistrie  characterized by both polar and nonpolar 309 
functional groups to facilitate extraction of compounds with a wide range of polarities were 310 
selected for evaluation. Evaluated polymer chemistries included Hydrophilic-Lipophilic Balance 311 
(HLB) particles synthesized in-house, commercially vailable SPE particles, a polar modified 312 
polystyrene-divinylbenzene copolymer (PS-DVB), a mix- ode (C8-SCX), and a 50:50 (w/w) 313 
HLB:PS-DVB. At the beginning of the study, preparation of the above listed SPME coatings was 314 
first attempted by spraying the particle slurry on the SPME blade’s surface, as described in 315 
earlier work by Mirnaghi et al [43]. However, due to the sharp edges of the blades and the 316 
roughness of the sprayed coating surface, attachment of matrix components, especially fatty 317 
residue was observed on the coating surface following extraction. To avoid coating fouling, the 318 
geometry of the SPME device was modified to include rounded rods, while smaller HLB 319 
particles (1-5 µm) were used to yield a smoother extraction phase surface, which prevented any 320 
further attachment of matrix constituents. A rounded SPME geometry has been previously 321 
utilized for extraction from complex biological matrices such as blood by Reyes-Garcés et al. 322 
[30] and Vuckovic et al. [44]. In addition, static extraction was carried out to totally prevent any 323 















When performing SPME in complex matrices, a rinsing step is usually added after the extraction 325 
step and prior to desorption so as to avoid fouling o  the sorbent surface. In the current work, 326 
water was selected as rinsing solvent. Agitation rate was set up at 900 rpm, and rinsing time was 327 
set at 10 seconds so as to avoid loss of polar analytes. 328 
Desorption-solvent effectiveness was assessed by evaluating desorption solutions with varied 329 
composition of the MeCN, MeOH, isopropanol, and water content. The effect of adding formic 330 
acid to the desorption solvent was also evaluated. Target analyte extraction amounts by each 331 
coating/desorption solvent pair are shown in Table S-6. These results were then compared with 332 
the aim of selecting the combination of extraction phase and desorption solvent composition that 333 
offers the highest extraction efficiency for most of the analytes, and the least carryover. The 334 
attained results, as summarized in Figure 2, showed that HLB provided the highest extraction 335 
recoveries for most of the target analytes, while mix- ode yielded the poorest recoveries. HLB 336 
yielded higher extraction recoveries for hydrophobic analytes, while PS-DVB yielded higher 337 
extraction recoveries for more polar compounds. Although the PS-DVB and 50:50 [w/w] 338 
HLB:PS-DVB coatings offered higher extraction efficiencies for polar compounds, they were 339 
also shown to be characterized by higher carryover eff cts for a number of compounds when 340 
submitted to second and third desorption cycles. As a result, HLB was selected for further 341 
method development as the functional coating polymer.  342 
3.3. Synthesis of Hydrophilic-Lipophilic Balance (HLB) particles 343 
FE-SEM images of the prepared HLB particles show that e attained particles are characterized 344 
by a uniform spherical shape, and are monodisperse in nature. Surface area analysis of the HLB 345 
particles revealed that the particles were microporus and mesoporous in nature, although most 346 















HLB particles, calculated via the Brunauer–Emmett–Teller(BET) method with nitrogen gas used 348 
as adsorbate at 77.35 K, was measured at 816.78 m2g-1.The SEM images in Figure S-3 (A and B) 349 
illustrate how particles initially agglomerated when dried under vacuum. The SEM images show 350 
the obtained particles were spherical in shape and of a size between 1-5 µm.  Although the HLB 351 
particles are embedded in PAN glue (Figure S-3, C and D), pores present in PAN allow analytes 352 
to access the different layers of the HLB coating. These pores enable the diffusion of analytes of 353 
interest into the coating but restrict access of macromoleculess such as proteins and lipids, 354 
resulting in satisfactory extraction of compounds of interest and minimal background 355 
interferences. At the same time, the smooth layer of PAN hinders attachment of matrix 356 
constituents to the SPME coating. 357 
3.4. Optimization of the desorption solvent by experimental design 358 
In order to optimize the desorption of the analytes under study, which are characterized by a 359 
wide range of polarities and physical-chemical prope ties, after extraction by the HLB coating, 360 
optimum desorption solvent composition was investigated via experimental design. In total, 14 361 
experiments in triplicate were performed, and the solvents portions were established through an 362 
SLMD with three components and the polynomial model gree equal to three. The use of 363 
SLMD for optimization of desorption solvent composition enables a much more efficient 364 
optimization process as compared to sequential testing, particularly when the goal of analysis is 365 
detection of a wide range of analytes. Figure 3 demonstrates the attained results for the tested 366 
compositions with respect to the HLB coating. In this work, the optimum desorption composition 367 
was selected as 25:37.5:37.5, v/v/v water: MeCN: MeOH. The optimum desorption solvent 368 
composition was in agreement with expected results; considering the wide range of Log P values 369 















fiber coating, while a sufficient amount of organic solvent would be needed to desorb non-polar 371 
compounds (Figure 3A). The same experimental design was used to assess carryover values; not 372 
surprisingly, the attained results converged with the above discussed results. The best conditions 373 
to minimize carryover were water (25%), MeCN (75%), and MeOH (0%) (Figure 3B). As this 374 
test was performed by using the inverse of values obtained for carryover, the maximum point 375 
denotes the lowest carryover obtained. Although the attained carryover percentage (less than 3% 376 
for all analytes, except for Phenylbutazone and Tolfenamic acid, at 5 and 8%, respectively) in the 377 
final desorption solution is considered acceptable in terms of quantitative analysis requirements, 378 
potential false positive results should be kept in mi d in cases where extractions from samples 379 
characterized by high concentrations of target compounds are followed by extractions from low 380 
concentration samples or blanks. Therefore, it is recommended that an additional desorption step 381 
is performed prior to the next SPME cycle. This additional desorption step, when combined with 382 
the conditioning step, allows for effective removal of residual analytes from the SPME coating. 383 
While addition of formic acid to the desorption solvent was found to improve overall desorption 384 
efficiency for most compounds, certain compounds, including lactams and fluoroquinolones, 385 
failed to present enough stability under such acidic conditions. Erythromycin, in particular, was 386 
observed to be very unstable under acidic conditions [45]. Thus, formic acid was not added to the 387 
final desorption solution selected in the developed method. 388 
3.5. Time profiles 389 
Extraction time profiles were determined by extracting spiked chicken samples at 1 MRL level at 390 
different time points, within the range of 10 – 60 minutes, under optimized conditions. 391 
According to the attained results, most polar compounds reached equilibrium within 60 minutes, 392 















this time period. As a compromise between extraction efficiency and overall analysis time, 60 394 
minutes was selected as the final extraction time. Figure S-4, in Supplementary data, presents the 395 
extraction time profiles of representative compounds from each class of veterinary drugs. Thus, 396 
under the selected extraction conditions, extraction of most hydrophobic compounds would 397 
occur under the pre-equilibrium regime. However, owing to the automation of the method, which 398 
enables precise control over extraction time, carrying out pre-equilibrium extractions will not 399 
affect the precision of the method. Desorption time profiles were determined by extracting 400 
spiked PBS samples at the 1 MRL level at various times (10 – 120 minutes). Although the results 401 
showed that most compounds reached quantitative desorption within only 15 minutes, 20 402 
minutes were selected as desorption time in order to minimize carryover of the most hydrophobic 403 
compounds. 404 
The final optimized SPME parameters presented in Figure 1 yielded sufficient extraction 405 
efficiency, minimum carryover, and minimum use of organic solvents, while affording minimum 406 
manual handling during the sample preparation steps. A total time of 1h 21m is needed to 407 
achieve SPME extraction and desorption; supposing the 96-pin system is fully utilized within a 408 
run of the proposed workflow (i.e., 96 samples per run), the proposed method thus offers a time 409 
per sample of less than 1 min. 410 
3.6. Matrix effect 411 
The presence of matrix effects (ME) is considered one f the main challenges in the multiresidue 412 
determination of drugs in tissue by LC-MS due to the complexity of the matrix under study. 413 
Matrix effects were calculated by the equation: ME% = (slope of matrix-matched calibration 414 















[12]. Matrix effects were evaluated for three different types of chicken tissues; breast, liver, and 416 
thighs. Figure 4 shows the matrix effects for the analytes studied versus their retention time. 417 
Absolute matrix effects were determined by the ratio of the peak areas of analytes spiked at three 418 
levels, low (0.3X), medium (0.9X), and high (2.5X), with extracts from the pooled matrix and 419 
neat standards at the same concentrations, as described by Matuszewski et al. [46]. Absolute 420 
matrix effects values are presented in Table 1 and Figure 5. Absolute matrix effect values for the 421 
majority of compounds were within the range of 80-120%. Only florfenicol amine displayed 422 
significant signal suppression (31%, 45% and 56% at 0.3X, 0.9X and 2.5X respectively), while 423 
six other compounds displayed significant ion enhancement at the 0.3X concentration level. No 424 
significant differences were observed when the results were calculated without normalization 425 
with internal standard. This is mainly due to the us  of matrix-matched calibration and minimal 426 
matrix effects offered by SPME which is capable of is lating and enriching target analytes with 427 
effective and efficient sample clean-up. However, we selected to use one internal standard in this 428 
method in order to compensate in case of variations from pin to pin, as well as variations in 429 
desorption solvent loss due to evaporation during the desorption step. The results confirm that 430 
SPME provides clean sample extracts, thus offering reliable results while minimizing analytical 431 
instrument maintenance requirements [26,27]. 432 
3.7. Validation of the method 433 
The target analytes in this work were selected to represent more than 12 classes of veterinary 434 
drugs varying in physiochemical properties. The developed method was validated following 435 
FDA guidelines for methods validation for drugs and biologics [40]. The selectivity of the 436 
method was evaluated via an analysis of blank chicken samples (n=10). No background peaks, 437 















showing that the method is free of endogenous interferences. Figure S-5 displays an example of 439 
obtained total ion chromatograms of blank chicken and blank chicken spiked at 0.1X and 1X 440 
levels. 441 
Method linearity was evaluated individually for each ompound through the establishment of 442 
matrix-matched calibration curves, which were prepad in a range of 0.1-3X in pooled chicken, 443 
and analyzed with the proposed SPME-LC-MS/MS method in triplicate. Pearson’s coefficient 444 
(R) values ranged from 0.9956 to 0.9999 for all analytes under study, indicating good correlation 445 
between both axes. Furthermore, the determination coeffi ient (R2) was higher than 0.991 for all 446 
compounds, and a lack of fit (LOF) test performed at the 5% level presented no significance 447 
difference (p> 0.05), indicating that well-adjusted models were obtained for all target 448 
compounds. 449 
Linear ranges, limits of quantitation, determination coefficients (R2), and lack of fit test results 450 
are presented in Table 1. 451 
The accuracy and precision of the method were calculated using six replicates per concentration 452 
(n=6) at three levels; low, mid, and high (0.3X, 0.9X and 2.5X). To evaluate the accuracy of the 453 
method, the mean relative recovery of the analyte was calculated by fortifying blank chicken 454 
samples at the three concentration levels mentioned above. The spiked samples were quantified 455 
using the matrix matched calibration curves. Accuray of the method as presented in Table 1 and 456 
Figure 5 was within 80-120% for all analytes except for Desethylene Ciprofloxacin (73%) 457 
Sulfadimethoxine (74%) and Tetracycline (63%) at low level concentration (0.3X), 458 
Oxyclozanide (60%) at mid level concentration (0.9X), 6-phenylthiouracil (134%), Albendazole 459 
(121%), and Oxytetracycline (121%) at high concentration level (2.5X). Intra-day and inter-day 460 















LOQs were calculated as the lowest point of the matrix matched calibration curves with RSD 462 
≤20%. LOQs equal to 0.1X were achieved for all analytes with the exceptions of 6-463 
Phenylthiouracil, Danofloxacin, Desethylene Ciproflaxin, Norfloxacin, and Triclabendazole with 464 
LOQ of 0.25X and Oxyclozanide 0.9X. This could be attributed to the low affinity of these 465 
analytes to the coating or due to poor ionization in electrospray ionization mass spectrometry. 466 
Stability results were evaluated by calculating the p rcentage decrease in calculated 467 
concentrations of analytes after 48 h, 72 h, and one week of storage in the desorption solvent 468 
relative to the concentration results from the first day of preparation. A statistically significant 469 
decrease was only observed after 1 week of storage for Tetracyclines and Lactams. All other 470 
analytes were found to be stable within the studied conditions. 471 
3.8. Application of final method towards analysis of chicken samples 472 
The final developed method was used to analyze chicken samples purchased from five local 473 
grocery stores. Three different types of chicken tissues were selected: breast, liver, and thighs. 474 
Most of the samples analyzed were free from the targe  analytes, except for chicken samples 475 
from one supplier, where the following analytes were p esent at levels below established MRLs: 476 
sulfapyridine, sulfamerazine, enrofloxacin, orbifloxacin, sulfamethizole, sulfamethazine, 477 
sulfamethoxypyridazine, sulfachloropyridazine, doxycycline, sulfadoxine, sulfamethoxazole, 478 
sulfaethoxypyridazine, sulfadimethoxine. Although the amounts detected were below limits of 479 
quantification, chicken thigh tissue was observed to present consistently higher values of the 480 
detected analytes in comparison to the other tested tissues. 481 















The developed method is the first and most comprehensiv  SPME approach to date for analysis 483 
of multiresidue veterinary drugs in meat in terms of the number of analytes tested as well as with 484 
respect to the range of physical and chemical properties covered. The method is fully automated, 485 
allowing for simultaneous analysis of up to 96 samples. Therefore, it offers a cost-effective 486 
alternative for analysis of veterinary drug residues in meat, additionally offering improved 487 
precision and shorter analysis times as compared to traditional sampling procedures.  488 
Given the growing public interest and concern regarding food safety, and taking into account the 489 
importance of the meat industry to the global economy, the demand for sophisticated, automated 490 
high-throughput analytical procedures for monitoring of drug residues in meat is expected to 491 
continue growing. The method is ideal for large-scale monitoring of multiresidue drugs, and is 492 
thus proposed as a valuable tool for regulatory monitori g and enforcement of MRLs. In addition 493 
to its superior performance and wide coverage, it is environmentally friendly due to the 494 
minimum amount of organic solvents needed as compared to traditional methods. Furthermore, it 495 
can be potentially adopted for other high-throughput analyses in biological, pharmaceutical, food 496 
science, and metabolomics applications. The proposed SPME method for analysis of 497 
multiresidue veterinary drugs in meat offers many advantages in comparison to currently adopted 498 
approaches. Notably, it offers fully automated and high-throughput monitoring, thus allowing for 499 
shorter analysis times per sample as compared to traditional sampling procedures. Further, the 500 
range of compounds detectable by the method include analytes from several drug classes, and of 501 
varying physical and chemical properties. The validation results and minimal matrix effects 502 
demonstrate that the method is suitable, reliable, and offers cleaner extracts as opposed to 503 
traditional methods. It is expected that the develop d method will be tested in the near future in 504 















interface to MS technologies Furthermore, studies to compare results of this method to other 506 
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Table 1. Validation of the developed method under optimized conditions (conditioning: 1.0 mL, 50/50 (MeOH/H2O, v/v) 30 min; extraction: 1.5mL diluted homogenized chicken, 60 min 514 
extraction time; rinsing: 1.0 mL H2O, 10 sec with agitation; desorption: 0.4 mL 37.5/37.5/25 (MeOH/MeCN/H2O, v/v/v), 20 min.) Accuracy (%) and intra-day precision (%RSD) 515 










ng g-1 Range LOQ R2 LOF 0.3X 0.9X 2.5X 0.3X 0.9X 2.5X 0.3X 0.9X 2.5X 0.3X 0.9X 2.5X 
2-Amino flubendazole 10 0.1 – 3X 0.1X 0.9968 0.1668 105 91 92 10 8 7 9 6 9 107 105 100 
5-HydroxyThiabendazole 100 0.1 – 3X 0.1X 0.9996 0.6585 90 98 107 3 3 4 5 6 8 102 100 102 
6-Phenylthiouracil 400 0.25 – 3X 0.25X 0.9991 0.7475 102 102 134 15 15 6 12 15 9 96 100 102 
Acepromazine 10 0.1 – 3X 0.1X 0.9993 0.9666 97 91 93 12 6 6 8 6 10 111 113 107 
Albendazole 50 0.1 – 1X 0.1X 0.9963 0.3941 91 94 121 4 6 3 11 16 17 86 93 96 
Albendazole 2 aminosulfone 50 0.1 – 3X 0.1X 0.9986 0.313 98 98 110 9 2 2 9 6 10 95 98 100 
Albendazole Sulfone 50 0.1 – 3X 0.1X 0.9996 0.9327 96 97 101 4 2 4 5 4 7 100 101 101 
Albendazole Sulfoxide 50 0.1 – 3X 0.1X 0.9997 0.9808 99 99 106 5 3 3 8 5 7 97 97 101 
Azaperone 10 0.1 – 3X 0.1X 0.9995 0.9611 90 88 96 6 1 5 6 5 8 105 92 99 
Betamethasone 100 0.1 – 3X 0.1X 0.9987 0.2617 103 103 98 3 3 4 6 4 10 111 110 109 
Cambendazole 10 0.1 – 3X 0.1X 0.9996 0.5943 97 98 102 3 2 3 6 6 4 111 104 101 
Carbadox 30 0.1 – 3X 0.1X 0.9994 0.888 90 93 105 3 5 6 6 8 11 93 104 102 
Chlorpromazine 10 0.1 – 3X 0.1X 0.9984 0.2482 94 95 114 11 7 2 10 11 8 110 107 104 
Chlortetracycline 200 0.1 – 3X 0.1X 0.9989 0.7779 104 94 94 10 9 6 11 7 10 106 108 111 
Clenbuterol 10 0.1 – 3X 0.1X 0.9981 0.17 95 101 101 4 8 8 6 9 8 106 103 106 
Clindamycin 100 0.1 – 3X 0.1X 0.9993 0.071 102 101 106 6 4 9 7 6 10 103 103 102 
Cloxacillin 10 0.1 – 3X 0.1X 0.9995 0.9664 100 96 102 6 4 4 9 7 10 119 98 100 
Danofloxacin 70 0.25 – 3X 0.25X 0.9971 0.0611 85 96 115 10 7 6 13 10 7 131 116 109 
Desethylene Ciproflaxin 100 0.25 – 3X 0.25X 0.9973 0.6129 73 98 114 26 8 3 31 13 10 130 130 106 
Diclofenac 200 0.1 – 2X 0.1X 0.9985 0.0504 110 92 100 3 4 2 6 7 5 99 100 99 
Dicloxacillin 100 0.1 – 3X 0.1X 0.9998 0.9945 102 99 109 9 6 6 7 6 8 131 100 100 















(X) precision (%) precision (%) effect (%) 
ng g-1 Range LOQ R2 LOF 0.3X 0.9X 2.5X 0.3X 0.9X 2.5X 0.3X 0.9X 2.5X 0.3X 0.9X 2.5X 
Difloxacin 50 0.1 – 3X 0.1X 0.9994 0.8808 103 97 100 8 5 6 7 6 7 104 106 108 
Dimetridazole 10 0.1 – 3X 0.1X 0.9982 0.4102 96 97 104 4 6 9 8 7 11 98 97 98 
Doxycycline 100 0.1 – 3X 0.1X 0.9993 0.7341 97 96 100 6 9 4 9 8 8 116 107 106 
Emamectin 10 0.1 – 3X 0.1X 0.9922 0.3439 110 105 107 4 5 6 13 12 9 101 99 102 
Enrofloxacin 20 0.1 – 3X 0.1X 0.9996 0.9574 97 99 114 7 6 4 8 6 9 114 106 105 
Erythromycin 125 0.1 – 3X 0.1X 0.9987 0.7575 90 94 98 11 8 7 9 6 10 109 113 109 
Fenbendazole 100 0.1 – 3X 0.1X 0.9934 0.0541 100 94 99 8 8 7 11 12 12 82 95 97 
Fenbendazole Sulfone 400 0.1 – 3X 0.1X 0.9991 0.8673 102 96 106 8 3 3 14 6 5 77 93 95 
Florfenicol amine 100 0.1 – 3X 0.1X 0.9966 0.5284 89 101 100 6 7 9 9 9 10 31 45 56 
Flubendazole 10 0.1 – 3X 0.1X 0.9993 0.4049 101 94 104 6 2 2 7 5 4 98 99 98 
Flunixin 10 0.1 – 2X 0.1X 0.9993 0.1371 102 94 103 2 1 2 8 8 8 97 97 99 
Haloperidol 10 0.1 – 3X 0.1X 0.9974 0.1244 106 92 106 6 8 8 9 6 9 105 105 104 
Hydroxy dimetridazole 50 0.1 – 3X 0.1X 0.9991 0.6471 100 95 104 6 3 9 10 5 11 97 101 101 
Hydroxy Ipronidazole 10 0.1 – 3X 0.1X 0.9995 0.6841 95 97 92 6 8 5 7 8 8 102 103 101 
Ipronidazole 10 0.1 – 3X 0.1X 0.9958 0.8951 102 97 105 3 7 11 9 7 10 99 98 101 
Ketoprophen 10 0.1 – 3X 0.1X 0.9996 0.7832 100 98 107 4 1 3 8 7 8 98 99 99 
Levamisole 100 0.1 – 3X 0.1X 0.9985 0.1678 92 96 106 3 3 5 4 6 9 99 102 101 
Lincomycin 100 0.1 – 2X 0.1X 0.9989 0.885 93 95 112 9 6 3 9 8 4 103 102 102 
Mebendazole 10 0.1 – 3X 0.1X 0.9988 0.1994 102 95 107 5 3 3 7 4 5 79 82 85 
Mebendazole amine 10 0.1 – 3X 0.1X 0.9996 0.7758 92 91 104 5 4 6 8 8 7 107 107 110 
Melengestrol Acetate 25 0.1 – 3X 0.1X 0.999 0.4051 108 90 98 3 2 5 11 9 9 94 93 92 
Morantel 150 0.1 – 3X 0.1X 0.9988 0.3643 94 94 98 4 7 6 5 6 8 103 105 111 
Norfloxacin 50 0.25 – 3X 0.25X 0.9972 0.1145 89 96 114 13 6 5 25 9 8 119 107 100 
Orbifloxacin 50 0.1 – 3X 0.1X 0.9997 0.9792 106 101 109 7 9 3 8 8 8 111 105 103 
Compound MRL 
(X) 




















ng g-1 Range LOQ R2 LOF 0.3X 0.9X 2.5X 0.3X 0.9X 2.5X 0.3X 0.9X 2.5X 0.3X 0.9X 2.5X 
Oxacillin 100 0.1 – 3X 0.1X 0.9969 0.1026 98 100 103 6 4 2 7 5 8 130 101 101 
Oxfendazole 800 0.1 – 3X 0.1X 0.9996 0.958 100 98 108 5 2 3 6 4 5 98 99 96 
Oxyclozanide 10 0.9 – 3X 0.9X 0.9912 0.267 ND 60 86 ND 15 13 ND 51 30 98 95 96 
Oxyphenylbutazone 100 0.1 – 3X 0.1X 0.9981 0.6933 102 101 109 6 7 2 9 8 5 96 97 98 
Oxytetracycline 200 0.1 – 3X 0.1X 0.994 0.349 88 104 121 9 12 7 14 12 12 120 118 114 
Phenylbutazone 100 0.1 – 3X 0.1X 0.9987 0.5731 92 101 114 4 10 3 8 8 5 97 99 97 
Pirlimycin 300 0.1 – 3X 0.1X 0.9992 0.4285 100 97 107 5 2 6 8 5 11 100 101 98 
Prednisone 100 0.1 – 3X 0.1X 0.998 0.9244 92 102 101 3 4 3 8 7 8 95 92 97 
Promethazine 10 0.1 – 3X 0.1X 0.9988 0.1956 98 97 110 10 9 6 9 8 8 112 112 108 
Propionylpromazine 10 0.1 – 3X 0.1X 0.9998 0.9644 94 94 115 7 9 5 6 9 8 107 106 100 
Ractopamine 30 0.1 – 3X 0.1X 0.9984 0.0569 94 97 107 4 4 5 6 7 8 98 101 104 
Sarafloxacin 50 0.1 – 3X 0.1X 0.9987 0.0651 90 107 100 6 6 7 20 8 13 114 111 104 
Sulfachloropyridazine 100 0.1 – 3X 0.1X 0.9986 0.2934 96 99 103 6 3 2 6 5 8 101 100 101 
Sulfadimethoxine 100 0.1 – 3X 0.1X 0.9927 0.583 126 96 113 24 15 12 34 16 17 126 114 106 
Sulfadoxine 100 0.1 – 3X 0.1X 0.9988 0.3358 99 100 107 3 2 4 5 5 6 104 102 101 
Sulfaethoxypyridazine 100 0.1 – 3X 0.1X 0.9998 0.7936 92 96 98 3 4 3 4 4 6 101 101 102 
Sulfamerazine 100 0.1 – 3X 0.1X 0.9991 0.5314 98 97 108 7 3 4 7 5 9 99 103 103 
Sulfamethazine 100 0.1 – 3X 0.1X 0.9986 0.2373 108 99 106 4 6 2 6 4 6 106 102 102 
Sulfamethizole 100 0.1 – 3X 0.1X 0.9977 0.1043 96 102 111 7 4 2 7 7 8 99 103 102 
Sulfamethoxazole 100 0.1 – 3X 0.1X 0.9987 0.7362 91 99 104 6 3 2 6 7 8 101 102 100 
Sulfamethoxypyridazine 100 0.1 – 3X 0.1X 0.9988 0.6857 103 99 100 5 3 1 6 5 5 107 107 104 
Sulfapyridine 100 0.1 – 3X 0.1X 0.9993 0.5457 94 99 108 4 4 3 5 6 7 101 100 101 
Sulfaquinoxaline 100 0.1 – 3X 0.1X 0.9998 0.9357 96 101 109 4 2 3 5 4 4 98 100 100 
Sulfathiazole 100 0.1 – 3X 0.1X 0.9992 0.0588 99 96 105 4 3 8 8 6 10 102 99 103 
Compound 






















Tetracycline 200 0.1 – 3X 0.1X 0.9952 0.6236 63 92 107 20 7 8 21 7 7 123 119 118 
Tolfenamic Acid 200 0.1 – 2X 0.1X 0.9993 0.2278 103 90 98 3 2 2 5 7 6 99 99 100 
Triclabendazole  50 0.25 – 2X 0.25X 0.9972 0.0772 106 84 97 4 4 6 8 12 10 96 96 97 
Triclabendazole Sulfoxide 50 0.1 – 2X 0.1X 0.9952 0.0621 103 88 103 9 6 4 18 12 9 97 98 99 
Trifluropromazine 10 0.1 – 3X 0.1X 0.9986 0.5501 101 93 110 8 7 7 10 9 8 100 103 100 
Tylosin 200 0.1 – 3X 0.1X 0.9962 0.0558 105 94 105 9 5 7 11 7 8 111 107 103 
Virginiamycin 100 0.1 – 3X 0.1X 0.9953 0.118 103 98 100 3 2 3 7 5 9 100 103 102 
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Figure 1. Concept 96-SPME device and SPME brush with 96 pins. Optimized conditions 519 
(time, agitation, solvent, and volume) for conditioning, extraction, rinsing, and desorption 520 
steps are shown, respectively, under each agitator-station. 521 
Figure 2. Evaluation of 4 SPME coatings (HLB, mix-mode, PS-DVB and 50:50 HLB:PS-522 
DVB) in different desorption solutions (Des 1: MeCN/H2O 50/50, Des 2: 523 
MeCN/MeOH/H2O/FA 40/40/20/0.1 and Des 3: MeCN/IPA/H2O/FA 40/40/20/0.1). 524 
Extraction volume:1000 µL, extraction time:120 min, concentration of analytes: 50 ng mL-525 
1, extraction matrix: 1X PBS. Desorption time: 120 min, desorption volume: 1000 µL. 526 
Figure 3. Optimum contour plot for special cubic model to fit experimental data for all 527 
compounds under study. (A: Desorption, B: Carryover). 528 
Figure 4. Matrix effects of the final method for target analytes in three chicken tissues 529 
(breast, liver, and thigh) plotted vs. retention time. 530 
Figure 5. Absolute matrix effects of the final method for target analytes. 531 
Figure 6. Accuracy of the final method for target analytes. 532 
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